MannKind | MNKD - Cash And Equivalent

Stock Price
5.69
Daily Change
-0.09 -1.56%
Monthly
1.25%
Yearly
0.71%
Q1 Forecast
5.60

MannKind reported $127.39M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Adma Biologics USD 61.38M 28.9M Sep/2025
Dynavax Technologies USD 160.25M 61.15M Sep/2025
Eli Lilly USD 9.79B 6.42B Sep/2025
Halozyme Therapeutics USD 419.66M 357.8M Sep/2025
Insmed USD 334.76M 949.56M Sep/2025
MacroGenics USD 80.13M 50.56M Sep/2025
MannKind USD 127.39M 70.39M Sep/2025
Merck USD 18.17B 10.16B Sep/2025
Novo Nordisk DKK 38.94B 24.15B Mar/2025
Pfizer USD 1.34B 295M Sep/2025
Sanofi EUR 7.66B 1.25B Dec/2025
Xencor USD 28.29M 16.15M Sep/2025